Are the Benefits of Nanopharmaceuticals Outweighing their Potential Risks?

Bushra Hassan Marouf

doi:10.54133/ajms.v8i1.1788

Authors

Bushra Hassan Marouf Department of Pharmacology and Toxicology, College of Pharmacy, University of Sulaimani, Kurdistan Region, Iraq https://orcid.org/0000-0002-7658-9013

DOI:

https://doi.org/10.54133/ajms.v8i1.1788

Keywords:

Benefits, Nanopharmaceuticals, Risks, Toxicity

Abstract

N/A

Downloads

Download data is not yet available.

References

Singh S, Pandey SK, Vishwakarma N, (Eds.), Functional nanomaterials for the cosmetics industry. In: Handbook of Functionalized Nanomaterials for Industrial Applications. Elsevier; 2020:717-730. doi: 10.1016/B978-0-12-816787-8.00022-3. DOI: https://doi.org/10.1016/B978-0-12-816787-8.00022-3

Meng G. Application of nanoparticles in cosmetics. TMBLS. 2024;4:69-75. doi: 10.62051/qcyb3q83. DOI: https://doi.org/10.62051/qcyb3q83

Hynes NRJ, Sankaranarayanan R, Kumar JPS, (Eds.), Nanoparticles and medicine. In: Nanomedicine Manufacturing and Applications. Elsevier; 2021:21-37. doi: 10.1016/B978-0-12-820773-4.00018-4. DOI: https://doi.org/10.1016/B978-0-12-820773-4.00018-4

Zein R, Sharrouf W, Selting K. Physical properties of nanoparticles that result in improved cancer targeting. J Oncol. 2020;2020:1-16. doi: 10.1155/2020/5194780. DOI: https://doi.org/10.1155/2020/5194780

Utreja P, Verma S, Rahman M, Kumar L. Use of nanoparticles in medicine. CBE. 2020;6(1):7-24. doi: 10.2174/2212711906666190724145101. DOI: https://doi.org/10.2174/2212711906666190724145101

Egbuna C, Parmar VK, Jeevanandam J, Ezzat SM, Patrick-Iwuanyanwu KC, Adetunji CO, et al. Toxicity of nanoparticles in biomedical application: Nanotoxicology. J Toxicol. 2021;2021:9954443. doi: 10.1155/2021/9954443. DOI: https://doi.org/10.1155/2021/9954443

Sharma S, Parveen R, Chatterji BP. Toxicology of nanoparticles in drug delivery. Curr Pathobiol Rep. 2021;9(4):133-144. doi: 10.1007/s40139-021-00227-z. DOI: https://doi.org/10.1007/s40139-021-00227-z

Pasut G. Grand challenges in nano-based drug delivery. Front Med Technol. 2019;1:1. doi: 10.3389/fmedt.2019.00001. DOI: https://doi.org/10.3389/fmedt.2019.00001

Nolte TM, Lu B. Size and dose of nanoparticles modulate between toxic and medicinal effect on kidney. OpenNano. 2024;16:100200. doi: 10.1016/j.onano.2024.100200. DOI: https://doi.org/10.1016/j.onano.2024.100200

Lu X, Zhu T, Chen C, Liu Y. Right or left: the role of nanoparticles in pulmonary diseases. Int J Mol Sci. 2014;15(10):17577-17600. doi: 10.3390/ijms151017577. DOI: https://doi.org/10.3390/ijms151017577

Arif T, Dorjay K, (Eds.), Nanoparticle toxicological risks on intact-skin dermal exposures. In: Nanocosmetics. Elsevier; 2020:403-409. doi: 10.1016/B978-0-12-822286-7.00023-1. DOI: https://doi.org/10.1016/B978-0-12-822286-7.00023-1

Tee JK, Ong CN, Bay BH, Ho HK, Leong DT. Oxidative stress by inorganic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016;8(3):414-438. doi: 10.1002/wnan.1374. DOI: https://doi.org/10.1002/wnan.1374

Thit A, Selck H, Bjerregaard HF. Toxic mechanisms of copper oxide nanoparticles in epithelial kidney cells. Toxicol In Vitro. 2015;29(5):1053-1059. doi: 10.1016/j.tiv.2015.03.020. DOI: https://doi.org/10.1016/j.tiv.2015.03.020

Manke A, Wang L, Rojanasakul Y. Mechanisms of nanoparticle-induced oxidative stress and toxicity. Biomed Res Int. 2013;2013:942916. doi: 10.1155/2013/942916. DOI: https://doi.org/10.1155/2013/942916

Kumar K. Assessment of toxicity and safety profiles of nanoparticles. Lett Appl NanoBioSci. 2020;10(1):1877-1888. doi: 10.33263/LIANBS101.18771888. DOI: https://doi.org/10.33263/LIANBS101.18771888